{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:31:04Z","timestamp":1758126664012},"publisher-location":"Chichester, UK","reference-count":51,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd005162.pub2","type":"reference-entry","created":{"date-parts":[[2007,2,6]],"date-time":"2007-02-06T14:25:39Z","timestamp":1170771939000},"source":"Crossref","is-referenced-by-count":17,"title":["Terlipressin for hepatorenal syndrome"],"prefix":"10.1002","author":[{"given":"Lise Lotte","family":"Gluud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette S","family":"Kjaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,10,18]]},"reference":[{"key":"10.1002\/14651858.CD005162.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0168-8278(98)80151-7","article-title":"Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome","volume":"29","author":"Hadengue","year":"1998","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/jhep.2003.50276","article-title":"Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study","volume":"38","author":"Pomier-Layrargues","year":"2003","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1440-1746.2003.02934.x","article-title":"Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial","volume":"18","author":"Solanki","year":"2003","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB4|cit4","first-page":"123","article-title":"[Efficacy of terlipressin in treatment of liver cirrhosis with hepatorenal syndrome]","volume":"7","author":"Yang","year":"2001","journal-title":"Journal of Internal Intensive Medicine"},{"key":"10.1002\/14651858.CD005162.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/00042737-200212000-00013","article-title":"Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2","volume":"14","author":"Alessandria","year":"2002","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1440-1746.2002.02816.x","article-title":"Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis","volume":"17","author":"Colle","year":"2002","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB8|cit8","first-page":"303","article-title":"Terlipressin and albumin combination treatment in hepatorenal syndrome","volume":"50","author":"Danalioglu","year":"2003","journal-title":"Hepato-Gastroenterology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","article-title":"Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study","volume":"36","author":"Duvoux","year":"2002","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0016-5085(89)91704-6","article-title":"Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure","volume":"97","author":"Fernandez-Seara","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.510270107","article-title":"Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion","volume":"27","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB12|cit12","first-page":"1053","article-title":"Successful conservative therapy of hepatorenal syndrome with vasopressin-1-receptor antagonist ornipressin","volume":"36","author":"Gulberg","year":"1998","journal-title":"Zeitschrift f\u00fcr Gastroenterologie"},{"key":"10.1002\/14651858.CD005162.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/hep.510300430","article-title":"Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine","volume":"30","author":"Gulberg","year":"1999","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00042737-200202000-00009","article-title":"Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study","volume":"14","author":"Halimi","year":"2002","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0168-8278(99)80025-7","article-title":"Octreotide in the treatment of the hepatorenal syndrome in cirrhotic patients","volume":"30","author":"Kaffy","year":"1999","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/ndt\/gfh930","article-title":"Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study","volume":"20","author":"Kiser","year":"2005","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1002\/14651858.CD005162.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","article-title":"Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study","volume":"122","author":"Moreau","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB18|cit18","first-page":"15","article-title":"Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study","volume":"64","author":"Mulkay","year":"2001","journal-title":"Acta Gastro-Enterologica Belgica"},{"key":"10.1002\/14651858.CD005162.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB20|cit20","first-page":"40","article-title":"Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study","volume":"40","author":"Restuccia","year":"2002","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0168-8278(96)80297-2","article-title":"Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome","volume":"25","author":"Salo","year":"1996","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB22|cit22","first-page":"78","article-title":"Terlipressin and gelafundin: safe therapy of hepatorenal syndrome","volume":"9","author":"Saner","year":"2004","journal-title":"European Journal of Medical Research"},{"key":"10.1002\/14651858.CD005162.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/hep.20044","article-title":"Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy","volume":"39","author":"Shawcross","year":"2004","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","article-title":"Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome","volume":"33","author":"Uriz","year":"2000","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB25|cit25","unstructured":"Terlipressin as treatment of patients with cirrhosis and hepatorenal syndrome. Effect on survival and renal function. Multicenter, randomised and prospective study. Ongoing study"},{"key":"10.1002\/14651858.CD005162.pub2-BIB26|cit26","unstructured":"Double-blind, randomised, placebo controlled trial of terlipressin for the treatment of type 1 hepatorenal syndrome. Ongoing study"},{"key":"10.1002\/14651858.CD005162.pub2-BIB27|cit27","unstructured":"A double-blind, randomised, placebo-controlled, multicentre phase III study of intravenous terlipressin in patients with hepatorenal syndrome type 1. Ongoing study"},{"key":"10.1002\/14651858.CD005162.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascitis and hepatorenal syndrome in cirrhosis. International Ascites Club","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0168-8278(00)80423-7","article-title":"Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem","volume":"32","author":"Arroyo","year":"2000","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1572-0241.2005.41381.x","article-title":"Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison","volume":"100","author":"Baik","year":"2005","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"key":"10.1002\/14651858.CD005162.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1665-2681(19)32154-4","article-title":"Hepatorenal syndrome","volume":"2","author":"Cardenas","year":"2003","journal-title":"Annals of Hepatology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0140-6736(82)91689-0","article-title":"Controlled trial of terlipressin ('Glypressin') versus vasopressin in the early treatment of oesophageal varices","volume":"2","author":"Freeman","year":"1982","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005162.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of hepatorenal syndrome in cirrhosis","volume":"105","author":"Gines","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis","volume":"123","author":"Gines","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","article-title":"Hepatorenal syndrome","volume":"362","author":"Gines","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005162.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/aje\/kwj069","article-title":"Bias in clinical intervention research","volume":"163","author":"Gluud","year":"2006","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00007890-199102000-00030","article-title":"Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome - experience in 300 patients","volume":"51","author":"Gonwa","year":"1991","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD005162.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1055\/s-2002-33870","article-title":"TIPS or vasoconstrictors for the treatment of hepatorenal syndrome type 1- effect on survival?","volume":"40","author":"Gulberg","year":"2002","journal-title":"Zeitschrift f\u00fcr Gastroenterologie"},{"key":"10.1002\/14651858.CD005162.pub2-BIB40|cit40","doi-asserted-by":"crossref","unstructured":"Ioannou GN Doust J Rockey DC Terlipressin for acute esophageal variceal hemorrhage Cochrane Database of Systematic Reviews 2003, Issue 1. Art. No.: CD002147. DOI: 10.1002\/14651858.CD002147","DOI":"10.1002\/14651858.CD002147"},{"key":"10.1002\/14651858.CD005162.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD005162.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1080\/003655202317316132","article-title":"Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis","volume":"37","author":"Lin","year":"2002","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00000539-200107000-00012","article-title":"Terlipressin for treating intraoperative hypotension: can it unmask myocardial ischemia?","volume":"93","author":"Medel","year":"2001","journal-title":"Anesthesia and Analgesia"},{"key":"10.1002\/14651858.CD005162.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2036.2004.02112.x","article-title":"Review article: pathogenesis and pathophysiology of hepatorenal syndrome - is there scope for prevention?","volume":"20","author":"Moller","year":"2004","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD005162.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1592\/phco.24.11.1050.36144","article-title":"The role of vasopressin in vasodilatory septic shock","volume":"24","author":"Obritsch","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1002\/14651858.CD005162.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000044879","article-title":"Circadian rhythm of arginine vasopressin in hepatorenal syndrome","volume":"78","author":"Pasqualetti","year":"1998","journal-title":"Nephron"},{"key":"10.1002\/14651858.CD005162.pub2-BIB47|cit47","unstructured":"Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2003"},{"issue":"4","key":"10.1002\/14651858.CD005162.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"key":"10.1002\/14651858.CD005162.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005162.pub2-BIB50|cit50","first-page":"806","article-title":"The hepatorenal syndrome in liver transplant recipients","volume":"57","author":"Seu","year":"1991","journal-title":"American Surgeon"},{"key":"10.1002\/14651858.CD005162.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/hep.20044","article-title":"Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy","volume":"39","author":"Shawcross","year":"2004","journal-title":"Hepatology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD005162.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:45:43Z","timestamp":1628531143000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD005162.pub2"}},"subtitle":[],"editor":[{"given":"Lise Lotte","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2006,10,18]]},"references-count":51,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005162.pub2","relation":{},"subject":[],"published":{"date-parts":[[2006,10,18]]}}}